Skip to main content Skip to main content
VitalDecades logo VitalDecades
Labs and biomarkers

Does Medicare cover a vitamin D test? Only for listed diagnoses, and the list depends on your region

Brian Keller Healthcare Costs & Consumer Research
12 min read

Who made it and how it was checked

By Brian Keller, Healthcare Costs & Consumer Research. Researched and drafted with AI assistance, then edited by the editor named here. Fact-checked by Sarah Whitcomb, Senior Health Editor, . Its sources are listed on this page. No licensed clinician has reviewed it. How we source.

Report an error on this page

Medicare has no national rule for vitamin D testing and never pays for it as screening. Seven regional contractors each publish a policy with two layers that must both fit: a coded list the claim system checks and a text a reviewer applies. Every code list includes vitamin D deficiency, osteoporosis and a BMI of 30 or more; none includes fatigue, a routine physical or a screening code. But the Wellpoint Federal and Noridian texts name no obesity or osteopenia, accept osteoporosis only with a low T-score or high fracture risk, and accept deficiency only on treatment for a listed condition.

Medicare covers a vitamin D blood test only when the order carries a reason your regional Medicare contractor accepts, and never as a screening test. We read all seven contractors' current policies on November 16, 2026. Each has two layers that must both fit: a coded list of diagnoses the claim system checks, and a policy text a reviewer applies. On the code lists, all seven accept vitamin D deficiency, osteoporosis, stage 3 or worse kidney disease and a BMI of 30 or more. None accepts fatigue, malaise, a routine physical or any screening code. The texts differ more. Wellpoint Federal's and Noridian's name no obesity or osteopenia and accept osteoporosis only with a T-score of -2.5 or lower, a fracture or a high fracture-risk score. They accept deficiency only on treatment for a condition they list.

On this page

The seven policies, and whose claims each one governs

Read November 16, 2026, from each local coverage determination (LCD) and its billing article in the CMS Medicare Coverage Database, and CMS's contractor jurisdiction pages. Dates are the current version's effective date.
Contractor and policyStates and territoriesRechecking a low level
CGS, L33996 (August 6, 2026)Kentucky, OhioAfter deficiency, only to confirm replacement; then "annual testing may be appropriate"
Wellpoint Federal, L37535 (April 1, 2026)Illinois, Minnesota, Wisconsin, Connecticut, Maine, Massachusetts, New Hampshire, New York, Rhode Island, VermontStable at 20 to 50 ng/mL: repeat "often unnecessary"; under 20 or over 60: may be reimbursed until normal
Palmetto GBA, L39391 (January 1, 2026)Alabama, Georgia, Tennessee, North Carolina, South Carolina, Virginia, West VirginiaUnder 30 ng/mL: one repeat after 12 weeks of supplements, one more within a rolling 12 months; "The medical record must reflect that the beneficiary has been compliant with supplementation"; "Annual testing should be rare"
WPS, L34658 (August 28, 2025)Iowa, Kansas, Missouri, Nebraska, Indiana, MichiganUp to 4 a year for deficiency, rickets or osteomalacia; once a year for other conditions
Noridian, L36692 (August 14, 2025)Alaska, Arizona, California, Hawaii, Idaho, Montana, Nevada, North Dakota, Oregon, South Dakota, Utah, Washington, Wyoming, American Samoa, Guam, Northern Mariana IslandsSame wording as Wellpoint Federal
First Coast, L33771 (October 29, 2020)Florida, Puerto Rico, U.S. Virgin IslandsNo more than three a year; once a year after levels reach normal
Novitas, L34914 (July 1, 2020)Arkansas, Colorado, Delaware, District of Columbia, Louisiana, Maryland, Mississippi, New Jersey, New Mexico, Oklahoma, Pennsylvania, Texas; for Part B, also Arlington and Fairfax counties and the cities of Alexandria, Fairfax and Falls Church in VirginiaUp to 3 a year (a general vitamin assay policy)

Which reasons pass: the code list and the policy text

Codes like E55.9 are the reason written on the order; five-digit codes like 82306 name the test.

Each policy has a billing article listing the diagnosis codes that "support medical necessity" for the test, and an LCD text that names the conditions. Passing the list is not enough on its own; CGS's article says "The correct use of an ICD-10-CM code listed below does not assure coverage of a service. The service must be reasonable and necessary in the specific case and must meet the criteria specified in this determination." We compared the seven code lists for the standard 25-hydroxy test (code 82306), code by code, from 183 codes (CGS) to 848 (WPS), and read each text for the same conditions.

Our comparison of the seven billing articles' covered ICD-10 codes for code 82306 and of each LCD's list of indications, read November 16, 2026. Novitas's text names no conditions, so it appears only in the code-list column.
Reason on the orderOn the code listNamed in the policy text
Vitamin D deficiency (E55.9)All seven; Wellpoint Federal and Noridian say the code is for deficiency from a condition on their list and "should not be used for any other indication"On its own: Palmetto GBA and WPS ("hypovitaminosis D"). To monitor replacement therapy: CGS, WPS, First Coast. Only on replacement therapy "related to a condition listed above": Wellpoint Federal, Noridian, Palmetto GBA
Age-related osteoporosis (M81.0)All sevenCGS, Palmetto GBA, WPS, First Coast; Wellpoint Federal and Noridian only with a T-score of -2.5 or lower, a fragility fracture, a FRAX score above their thresholds, or before starting a bisphosphonate
Osteopenia (M85.8 codes)All seven (Palmetto GBA's list has no unspecified-site code)CGS, Palmetto GBA, WPS, First Coast; not Wellpoint Federal or Noridian, though Wellpoint's article tells coders which codes to use for it
BMI of 30 or more (Z68.30 and higher)All sevenObesity: CGS, Palmetto GBA (BMI of 30 or more), WPS, First Coast; not Wellpoint Federal or Noridian
Kidney disease, stage 3 or worse (N18.3 to N18.6)All sevenAll six texts that list conditions
Long-term steroid use (Z79.52)All except CGSPalmetto GBA, WPS, First Coast (medicines that lower vitamin D levels)
Status after weight-loss surgery (Z98.84)Palmetto GBA, WPS, First Coast, NovitasPalmetto GBA, WPS ("gastric bypass"), First Coast
Psoriasis (L40 codes)Wellpoint Federal, WPS, Noridian, First Coast, NovitasWPS, First Coast
Fibromyalgia (M79.7)WPS, First Coast, NovitasWPS
Obesity, unspecified (E66.9)None; the BMI code is what the lists acceptNot applicable
Fatigue (R53.83) or malaise (R53.81)NoneNone
Routine adult exam (Z00.00, Z00.01)NoneNone
Any screening code (Z13)NoneNone; six texts rule out screening, and First Coast's is silent
Falls or fall risk (R29.6, Z91.81)NoneNone

Where the two layers disagree, as at Wellpoint Federal and Noridian for obesity and osteopenia, a claim can pass the automated check and still fail if the record is reviewed against the text. That is our reading of how the two fit together, based on the article wording above; ask the ordering office which reason it will use and whether it fits the policy text as well as the list.

Which region's policy is yours

It may not be your home state's. CMS's claims manual says jurisdiction for an independent laboratory's claims "normally lies with the carrier serving the area in which the laboratory test is performed." It adds two exceptions: "there are some situations where a regional or national lab chain jurisdiction is with a single carrier," and when a lab sends your sample on to another lab in a different region for more tests, "the carrier servicing the referring laboratory retains jurisdiction for services performed by the other laboratory." The simplest check is to ask the lab which Medicare contractor processes its claims.

What to ask before the blood is drawn

  • What reason will be on the order? If it is fatigue, "annual labs" or a routine physical, expect a denial in every region.
  • Is there a true covered reason? Kidney disease, osteoporosis, malabsorption or a parathyroid problem may already be in your record; check the row for your region above. Tell the clinician about conditions that apply; never ask for one that does not.
  • Which test is ordered? The 25-hydroxy test (Medicare pays $29.60) is the standard one. For the 1,25-dihydroxy test ($38.50), Wellpoint Federal, Palmetto GBA, WPS and Noridian keep separate, shorter code lists (17 to 124 codes, against 362 to 848 for the standard test); the CGS and First Coast articles cover the 25-hydroxy test only, and First Coast's text says the 1,25 test "is primarily indicated during patient evaluations for hypercalcemia and renal failure"; Novitas uses one list for both.
  • Is this a recheck of a low level? Every policy allows rechecks to confirm treatment is working, but Wellpoint Federal, Noridian and Palmetto GBA tie them to a condition on their list, and Palmetto expects 12 weeks of supplements first, with records showing you took them.

If the lab expects a denial, it should give you an Advance Beneficiary Notice before the draw; our guide to the Medicare ABN for lab tests explains the three choices. Paying cash instead? Our vitamin D price comparison compares three sellers' prices.

Should you be tested at all?

For most adults, the coverage rule and the medical advice point the same way. The USPSTF (April 13, 2021) found the evidence insufficient to assess screening adults without symptoms, and the Endocrine Society's 2024 guideline "suggests against routine 25(OH)D testing in the absence of established indications." Our guide to who needs vitamin D supplements covers the groups that guideline does recommend supplements for, which is a different question from testing.

What we checked and what we did not

We read the seven current local coverage determinations and their billing articles through the CMS Medicare Coverage Database (the coded lists and article notes from its public API), CMS's twelve A/B contractor jurisdiction pages, chapter 1 of the claims manual, the 2026 lab fee schedule, the USPSTF statement and the Endocrine Society abstract on PubMed (title checked). We compared code lists for the 25-hydroxy test and counted, but did not compare, the separate 1,25-dihydroxy lists. We did not test how any contractor's claim system applies its lists or limits, and Medicare Advantage plans may set their own rules.

Wellpoint Federal is the name the coverage database gives the contractor for jurisdictions 6 and K, which CMS's jurisdiction pages list as National Government Services. The database also lists WPS's policy in most states, through a WPS Part A contract (number 05901); the regional contractors in the table are the ones that process Part B claims, which is how independent labs bill. Novitas is the only one of the seven without a vitamin D policy of its own: its "Assays for Vitamins and Metabolic Function" policy covers vitamin D alongside other vitamin and metabolic tests, and names no conditions for vitamin D in its text.

Every Medicare rate and coverage rule on this page was checked against the pages listed under Sources on November 16, 2026.

Frequently asked questions

Does Medicare cover a vitamin D test?

Only with a reason your regional contractor accepts in both its code list and its policy text, such as osteoporosis or chronic kidney disease stage 3 or worse. It never covers vitamin D testing as a screening test.

Does Medicare cover a vitamin D test for osteopenia?

All seven code lists include osteopenia codes, but only four policy texts name osteopenia: CGS, Palmetto GBA, WPS and First Coast. The Wellpoint Federal and Noridian texts do not, so in their regions ask whether another listed condition applies.

Will Medicare pay for a vitamin D test if I am tired all the time?

Not on that reason alone: fatigue (R53.83) is on none of the seven code lists or texts. A clinician evaluating fatigue may find another reason that is covered.

How often will Medicare pay for a vitamin D test?

It depends on the region. First Coast allows no more than three a year, Novitas up to three, WPS up to four for deficiency, and Palmetto GBA one recheck after 12 weeks and one more within a rolling 12 months. CGS, Wellpoint Federal and Noridian set no yearly count; see the table.

What does Medicare pay for a vitamin D test?

$29.60 to the lab for the 25-hydroxy test and $38.50 for the 1,25-dihydroxy test in 2026. You usually pay nothing for a covered diagnostic lab test on Original Medicare.

12 sources

These are the sources this guide cites, with each source's date where it publishes one. How we source.

Read next

How often does Medicare pay for a lipid panel? Every 5 years to screen, more often once you are treated

Medicare pays for a screening lipid panel once every 5 years, counted in months: no screening may be paid in the 59 months after the month of your last one. With a covered diagnosis such as high cholesterol, diabetes or high blood pressure, the test is diagnostic instead, and Medicare's national rule allows a yearly panel and, in the first year of treatment, any one part up to six times. A family history of heart disease or smoking, alone, does not count; a relative with familial hypercholesterolemia or high Lp(a) is on the code list, but a reviewer can still treat the test as screening.

Continue reading

Newsletter

One email a week: what changed, what it costs, what to do. Every item sourced and dated.

You're on the list. Look for your first issue next week.

No spam. Unsubscribe anytime.

Was this helpful?

Your feedback shapes what we cover next.

Thanks for letting us know.

If you found this useful, sign up for our newsletter to get more like this.

Thanks. What was missing?

Optional. We read every response.

Thanks.

We use this to prioritize the next round of edits.

Related Articles

More from Brian Keller

More in Labs and biomarkers